tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market

Acrivon Therapeutics, Inc. (ACRV) Financial Statements

119 Followers

Acrivon Therapeutics, Inc. Financial Overview

Acrivon Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.88; its P/E ratio is -2.55; Acrivon Therapeutics, Inc. is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue---$ 134.00K-
Gross Profit---$ 134.00K-
EBIT$ -17.67M$ -21.05M$ -13.91M$ -12.76M-
EBITDA$ -17.44M$ -20.90M$ -14.48M$ -13.79M-
Net Income Common Stockholders$ -16.49M$ -19.25M$ -13.91M$ -12.76M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 109.97M$ 127.46M$ 150.95M$ 120.21M$ 127.75M
Total Assets$ 120.52M$ 138.26M$ 160.05M$ 170.20M$ 181.23M
Total Debt$ 4.45M$ 4.64M$ 4.60M$ 4.79M$ 4.96M
Net Debt$ -105.53M$ -122.81M$ -146.35M$ -115.43M$ -122.79M
Total Liabilities$ 12.54M$ 17.07M$ 10.87M$ 9.73M$ 10.75M
Stockholders Equity$ 107.98M$ 121.19M$ 149.18M$ 160.47M$ 170.47M
Cash Flow-
Free Cash Flow$ -17.90M$ -13.52M$ -9.15M$ -11.41M$ -9.61M
Operating Cash Flow$ -17.08M$ -12.37M$ -9.04M$ -11.38M$ -9.35M
Investing Cash Flow$ 5.85M$ 20.54M$ 19.34M$ 9.33M$ -95.07M
Financing Cash Flow$ -172.00K$ -2.01M$ 379.00K-$ 101.86M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

Acrivon Therapeutics, Inc. Debt to Assets

Acrivon Therapeutics, Inc. Cash Flow

Acrivon Therapeutics, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis